These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19554889)

  • 1. [Conflicts of interest and clinical drug trials -- impact of the pharmaceutical industry and the impingement on the integrity of medical science].
    Ludwig WD; Hildebrandt M; Schott G
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(3):149-54. PubMed ID: 19554889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression.
    Cosgrove L; Krimsky S; Wheeler EE; Peters SM; Brodt M; Shaughnessy AF
    Account Res; 2017; 24(2):99-115. PubMed ID: 27901595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a clinical trial governance framework for pharmaceutical industry-funded clinical trials.
    Nair SC; AlGhafli S; AlJaberi A
    Account Res; 2018; 25(7-8):373-386. PubMed ID: 30249125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conflicts of interest: honours or honoraria.
    Sivakumaran M
    Lancet; 2003 Sep; 362(9387):922. PubMed ID: 13678996
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medicine: conflicts of interest in research].
    Fallena-Zonana M; Kraus-Weisman A
    Rev Invest Clin; 2003; 55(3):339-46. PubMed ID: 14515679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Objectivity in research in the pharmaceutical industry is possible].
    Torfs K; Rudolph I; Mehnert A; Sindern J
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(3):177-83. PubMed ID: 20608244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between medicine and industry: approaches to the problem of conflicts of interest.
    Raad R; Appelbaum PS
    Annu Rev Med; 2012; 63():465-77. PubMed ID: 21888513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.
    Coleman DL; Kazdin AE; Miller LA; Morrow JS; Udelsman R
    Acad Med; 2006 Feb; 81(2):154-60. PubMed ID: 16436576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. True, false, whatever.
    Schultz S
    US News World Rep; 2001 Sep; 131(10):72-3. PubMed ID: 11573469
    [No Abstract]   [Full Text] [Related]  

  • 11. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
    Lachin JM
    Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good practice for publishing the results of clinical trials.
    Wager E
    J Br Menopause Soc; 2005 Sep; 11(3):109-11. PubMed ID: 16157002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conflicts of interest in research involving human beings.
    Greco D; Diniz NM
    J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conflicts of interest in drug development: the practices of Merck & Co., Inc.
    Hirsch LJ
    Sci Eng Ethics; 2002 Jul; 8(3):429-42. PubMed ID: 12353373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology.
    Prendergast MM; Abramovits W; Boguniewicz M; Lebwohl M; Tokar M; Tong KB
    J Invest Dermatol; 2004 Sep; 123(3):452-4. PubMed ID: 15304081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Financial conflict of interest in clinical psychiatry studies: a review].
    Ulaş H; Binbay T; Alptekin K
    Turk Psikiyatri Derg; 2008; 19(4):418-26. PubMed ID: 19110984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the pharmaceutical industry influence guidelines?: two examples from Germany.
    Schott G; Dünnweber C; Mühlbauer B; Niebling W; Pachl H; Ludwig WD
    Dtsch Arztebl Int; 2013 Sep; 110(35-36):575-83. PubMed ID: 24078837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflicts of interest in biomedical research--the FASEB guidelines.
    Brockway LM; Furcht LT;
    FASEB J; 2006 Dec; 20(14):2435-8. PubMed ID: 17142792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Good Publication Practice for Pharmaceutical Companies": where are we now?
    Wager E
    MedGenMed; 2005 Apr; 7(2):6. PubMed ID: 16369385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.